MPWT
CUE icon

MassMutual Private Wealth & Trust’s Cue Biopharma CUE Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-81
Closed -$12K – 1551
2022
Q1 		$12K Buy
81
+21
+35% +$4.45K ﹤0.01% 699
2021
Q4 		$20K Buy
60
+34
+131% +$13.1K ﹤0.01% 602
2021
Q3 		$11K Hold
26
– – ﹤0.01% 692
2021
Q2 		$9K Buy
+26
New +$10.1K ﹤0.01% 690

Other funds holding CUE

PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

MassMutual Private Wealth & Trust's CUE Position: Q2 2022 in Review

MassMutual Private Wealth & Trust sold out of Cue Biopharma (CUE) in Q2 2022, closing a stake of 81 shares — an estimated $12K sold.

MassMutual Private Wealth & Trust first reported a position in CUE in Q2 2021 and held it in 4 quarters. The position peaked at $20K in Q4 2021. 75 funds tracked by Wall St. Rank hold CUE as of Q2 2022.

  • MassMutual Private Wealth & Trust reported no remaining Cue Biopharma position as of Q2 2022 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 81 Cue Biopharma shares in Q2 2022, an estimated $12K.
  • MassMutual Private Wealth & Trust first reported a position in Cue Biopharma in Q2 2021 and held it in 4 quarters.
  • MassMutual Private Wealth & Trust's Cue Biopharma position peaked at $20K in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2022, filed 7 Jul 2022.